The worldwide market for bariatric surgical devices — the surgical device treatment of obesity — is growing at an alarming rate as a result of increasing prevalence in obesity. Data from the World Health Organization and International Obesity Task Force (see report #S825) illustrates how significant both the direct and indirect costs are that are associated with obesity. Given the correlation between obesity and diabetes and heart disase, it is clear that money spent directly on obesity has the potential to eliminate indirect costs nearly as high.
For the U.S., this is particularly important, since the U.S. represents a growing share of the world’s obese population.
Below is the market for bariatric surgical devices by major geographic region.
Note: These figures include sales of devices such as gastric bands, gastric stimulation devices, brain stimulation devices and other non-pharmaceutical devices available only through a physician. Unless otherwise mentioned, the unit and sales figures do not include sales of common surgical devices that may have been adapted for use in morbidly obese patients, such as minimally invasive surgical equipment, staplers and other closure devices, longer-handled hemostats, longer retractors, etc.
Source: Report #S825, "Worlwide Market for the Clinical Management of Obesity."